FDA Clears First Nucleic Acid Amplification Test To Detect Common Sexually Transmitted Infection Trichomonas Vaginalis
Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing its APTIMA Trichomonas vaginalis assay on the fully automated TIGRIS system. The APTIMA assay is the first amplified nucleic acid test specifically cleared to detect Trichomonas vaginalis, the most common curable sexually transmitted infection in the United States. The ...

FDA needs teeth to avert drug shortages
The number of medications in short supply has been rising, including some needed daily in hospitals, and regulators lack the tools to address the problem. One Senate bill in the works could help. It didn't used to be in Sandy Binder's job description to be a drug sleuth.